An unusual case of acute respiratory distress syndrome in a young man
Abstract
Acute Respiratory Distress Syndrome (ARDS) is a complex and progressive lung injury that results in respiratory failure, often caused by pulmonary or systemic disorders. We present a 32-year-old male who developed ARDS following intranasal inhalation of cocaine. Diagnosis was established thorough clinical evaluation, identification of characteristic ultrasonographic patterns, and careful exclusion of other potential causes. The patient was managed with conservative medical therapy, including non-invasive ventilation, bronchodilators, antibiotic therapy, and comprehensive supportive care. Despite initial concerns about the severity of his condition, the patient's outcome was favourable, reflecting the diverse presentations and potential reversibility of ARDS. This case highlights two main aspects: i) the critical role of emergency physicians in recognizing and managing ARDS, even when the underlying cause is not immediately apparent; and ii) the importance of considering illicit drug use as a potential trigger during the initial assessment of respiratory complications.
References
- Diamond M, Peniston HL, Sanghavi DK, et al. Acute Respiratory Distress Syndrome. [Updated 2024 Jan 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK436002/
- Matthay MA, Arabi Y, Arroliga AC, et al. A new global definition of acute respiratory distress syndrome. Am J Respir Crit Care Med 2024;209:37-47. DOI: https://doi.org/10.1164/rccm.202303-0558WS
- Gajic O, Dabbagh O, Park PK, et al. Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med 2011;183:462-70. DOI: https://doi.org/10.1164/rccm.201004-0549OC
- Wang Y, Zhang L, Xi X, et al. The association between etiologies and mortality in acute respiratory distress syndrome: a multicenter observational cohort study. Front Med (Lausanne) 2021;8:739596. DOI: https://doi.org/10.3389/fmed.2021.739596
- Zambon M, Vincent JL. Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest 2008;133:1120-7. DOI: https://doi.org/10.1378/chest.07-2134
- Hirche TO, Lambrecht E, Wagner TO. Crack-Syndrom: Pulmonale Komplikationen nach Kokaininhalation--Kasuistik und Darstellung des Krankheitsbildes [Crack-syndrome: the pulmonary complications of inhaled cocaine. A review a propos a case report]. Pneumologie 2002;56:684-8. German. DOI: https://doi.org/10.1055/s-2002-35552
- Wilson KC, Saukkonen JJ. Acute respiratory failure from abused substances. J Intensive Care Med 2004;19:183-93. DOI: https://doi.org/10.1177/0885066604263918
- Chudasama K, Seenath M, Gourevitch D. Pneumomediastinum after cocaine use: an unusual aetiology. J Surg Case Rep 2010;2010:3. DOI: https://doi.org/10.1093/jscr/2010.1.3
- Ishikawa O, Jen H. Blown by blow: an usual etiology of pneumomediastinum. Am J Respir Crit Care Med 2018;197:A6635.
- Perper JA, Van Thiel DH. Respiratory complications of cocaine abuse. Recent Dev Alcohol 1992;10:363-77. DOI: https://doi.org/10.1007/978-1-4899-1648-8_18
- Restrepo CS, Carrillo JA, Martínez S, Ojeda P, Rivera AL, Hatta A, et al. Pulmonary complications from cocaine and cocaine-based substances: Imaging manifestations. Radiographics 2007;27:941–56. DOI: https://doi.org/10.1148/rg.274065144
- Forrester JM, Steele AW, Waldron JA, Parsons PE. Crack lung: An acute pulmonary syndrome with a spectrum of clinical and histopathologic findings. Am Rev Respir Dis 1990;142:462–7. DOI: https://doi.org/10.1164/ajrccm/142.2.462
- Bontempo LJ, Magidson PD, Hayes BD, Martinez JP. Acute pulmonary injury after inhalation of free-base cocaine: a case report. J Acute Med 2017;7:82-6.
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2024 the Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.